共 20 条
[1]
Fischer K(2012)Bendamustine in combination with rituximab for previously untreated patients with chronic lymphocytic leukaemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukaemia Study Group J Clin Oncol 30 3209-3216
[2]
Cramper P(2013)Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial Lancet 6736 61763–2-2378
[3]
Busch R(2002)Pooled analysis of clinical and cytogenetic features in treatment-related and the novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976–1993 and on 5098 unselected cases reported in the literature 1974–2001 Leukemia 16 2366-1328
[4]
Böttcher S(2012)Bendamustine can severely impair T cell immunity against cytomegalovirus Leuk Lymphoma 54 1327-757
[5]
Bahlo J(2013)Myeloid leukemia cells with a B7-2+ subpopulation provoke Th cell responses and become immune-suppressive through the modulation of B7 ligands Eur. J. Immunol 43 747-undefined
[6]
Schubert J(undefined)undefined undefined undefined undefined-undefined
[7]
Rummel MJ(undefined)undefined undefined undefined undefined-undefined
[8]
Niederle N(undefined)undefined undefined undefined undefined-undefined
[9]
Maschmeyer G(undefined)undefined undefined undefined undefined-undefined
[10]
Mauritzon N(undefined)undefined undefined undefined undefined-undefined